Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Transdermal Estradiol in Postmenopausal Women with COVID-19
NCT05774405Phase 2Completed
- Sponsor
- Istanbul University-Cerrahpaşa
- Start
- Jul 2020
- Primary completion
- Jul 2021
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of estradiol topical in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Istanbul University-Cerrahpaşa. Primary endpoints: Evidence of disease progression for mild cases at 15 days, Evidence of disease progression for moderate and severe cases at 15 days and 4 more. Started Jul 2020; status: completed.
02
Drugs
estradiol topical
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05774405.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05774405.